Rapport Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2022-01-01
- Employees
- 58
- Market Cap
- -
- Website
- http://www.rapportrx.com
Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Rapport Therapeutics Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06377930
- Locations
- 🇺🇸
Emory Brain Health Center, Atlanta, Georgia, United States
🇺🇸Yale University, New Haven, Connecticut, United States
🇺🇸Consultants in Epilepsy and Neurology, PLLC, Boise, Idaho, United States
© Copyright 2025. All Rights Reserved by MedPath